Migraine is ranked as the third most prevalent disorder, the eight most burdensome disease and the seventh cause of disability worldwide [1]. Although its prevalence decreases after the age of 60, it still affects 7% of women and 3% of men over 65. A successful treatment of a late-life migraine is particularly important due to the association with increased risk of ischemic stroke, white matter lesions and other transient neurological phenomena (migraine accompaniments) responsive to prophylactic medications

How do you choose the appropriate migraine pharmacotherapy for an elderly person? / Curto, Martina; Capi, Matilde; Martelletti, Paolo; Lionetto, Luana. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 20:1(2019), pp. 1-3. [10.1080/14656566.2018.1543660]

How do you choose the appropriate migraine pharmacotherapy for an elderly person?

Curto, Martina
;
Capi, Matilde;Martelletti, Paolo;
2019

Abstract

Migraine is ranked as the third most prevalent disorder, the eight most burdensome disease and the seventh cause of disability worldwide [1]. Although its prevalence decreases after the age of 60, it still affects 7% of women and 3% of men over 65. A successful treatment of a late-life migraine is particularly important due to the association with increased risk of ischemic stroke, white matter lesions and other transient neurological phenomena (migraine accompaniments) responsive to prophylactic medications
2019
aging; elderly; migraine; pharmacotherapy; treatment; pharmacology; pharmacology (medical)
01 Pubblicazione su rivista::01a Articolo in rivista
How do you choose the appropriate migraine pharmacotherapy for an elderly person? / Curto, Martina; Capi, Matilde; Martelletti, Paolo; Lionetto, Luana. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 20:1(2019), pp. 1-3. [10.1080/14656566.2018.1543660]
File allegati a questo prodotto
File Dimensione Formato  
Curto_How-do-you_2019 .pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 659.17 kB
Formato Adobe PDF
659.17 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1267171
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 7
social impact